ORAGENICS, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
ORAGENICS, INC. (OGEN) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $49.59 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2025-03-14
- ORAGENICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was $49.59K, a 1.02% increase from fiscal 2023.
- ORAGENICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was $49.09K, a 30.69% decline from fiscal 2022.
- ORAGENICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was $70.83K.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month |
|---|---|
| 2024-12-31 | $49.59K 10-K · filed 2025-03-14 |
| 2023-12-31 | $49.09K 10-K · filed 2025-03-14 |
| 2022-12-31 | $70.83K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |